"Carcinoma, Small Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)
|Carcinoma, Small Cell
- Carcinoma, Small Cell
- Carcinomas, Small Cell
- Small Cell Carcinomas
- Oat Cell Carcinoma
- Small Cell Carcinoma
- Carcinoma, Oat Cell
- Carcinomas, Oat Cell
- Oat Cell Carcinomas
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Small Cell".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Small Cell".
This graph shows the total number of publications written about "Carcinoma, Small Cell" by people in this website by year, and whether "Carcinoma, Small Cell" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Carcinoma, Small Cell" by people in Profiles.
Autoimmune gastrointestinal dysmotility due to small cell lung cancer. BMJ Case Rep. 2017 Aug 11; 2017.
Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance). J Clin Oncol. 2017 Jul 01; 35(19):2184-2192.
Upstaging of nonurothelial histology in bladder cancer at the time of surgical treatment in the National Cancer Data Base. Urol Oncol. 2017 01; 35(1):34.e1-34.e8.
Metastatic small cell carcinoma of the prostate: Population-based analysis of patient characteristics and treatment paradigms. Urol Oncol. 2015 Feb; 33(2):70.e1-7.
A personalized treatment for lung cancer: molecular pathways, targeted therapies, and genomic characterization. Adv Exp Med Biol. 2014; 799:85-117.
Combined MET inhibition and topoisomerase I inhibition block cell growth of small cell lung cancer. Mol Cancer Ther. 2014 Mar; 13(3):576-84.
Primary gastric combined adeno- small cell neuroendocrine carcinoma. Trop Gastroenterol. 2013 Jul-Sep; 34(3):197-9.
Etoposide and temozolomide in combination for the treatment of progressive small-cell lung cancer central nervous system metastases: two cases. Tumori. 2013 Mar-Apr; 99(2):e73-6.
Management of primary hepatopancreatobiliary small cell carcinoma. J Surg Oncol. 2013 Jun; 107(7):692-5.
Cisplatin, irinotecan, and bevacizumab for untreated extensive-stage small-cell lung cancer: CALGB 30306, a phase II study. J Clin Oncol. 2011 Nov 20; 29(33):4436-41.